DOPA RESORPTION AND DOPAMINE ESTIMATION IN BLOOD OF PATIENTS WITH PARKINSONS-DISEASE

被引：2

作者：

METZEL, E ^{[1
]}

WEITBRECHT, WU ^{[1
]}

机构：

[1] UNIV FREIBURG, NEURO CHIRURG KLIN, HUGSTETTER STR 55, D-7800 FREIBURG, WEST GERMANY

来源：

ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN | 1974年 / 219卷 / 03期

关键词：

D O I：

10.1007/BF00342049

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：231 / 237

页数：7

共 50 条

[41] EFFECT OF L-DOPA ON COURSE OF PARKINSONS-DISEASE
CURTIS, L
LEES, AJ
STERN, GM
MARMOT, MG
LANCET, 1984, 2 (8396): : 211 - 212
[42] MECHANISMS OF ACTION OF L-DOPA IN PARKINSONS-DISEASE
HORNYKIEWICZ, O
LIFE SCIENCES, 1974, 15 (07) : 1249 - 1259
[43] ANTI-DEPRESSIVE TREATMENT IN PARKINSONS-DISEASE - A CONTROLLED TRIAL OF THE EFFECT OF NORTRIPTYLINE IN PATIENTS WITH PARKINSONS-DISEASE TREATED WITH L-DOPA
ANDERSEN, J
AABRO, E
GULMANN, N
HJELMSTED, A
PEDERSEN, HE
ACTA NEUROLOGICA SCANDINAVICA, 1980, 62 (04): : 210 - 219
[44] INITIAL RESPONSE TO L-DOPA IN PARKINSONS-DISEASE
GANCHER, ST
NUTT, JG
ANNALS OF NEUROLOGY, 1987, 22 (01) : 173 - 173
[45] BENSARAZID WITH L-DOPA IN TREATMENT OF PARKINSONS-DISEASE
VANWIERINGEN, A
SOUTH AFRICAN MEDICAL JOURNAL, 1974, 48 (06): : 206 - 209
[46] IMPORTANCE OF AMANTADINE IN TREATMENT OF PARKINSONS-DISEASE BY L DOPA
BALLIVET, J
DUMAS, R
LYON MEDICAL, 1973, 229 (02): : 151 - 154
[47] LONGEVITY IN PARKINSONS-DISEASE TREATED WITH L-DOPA
BIRKMAYER, W
AMBROZI, L
NEUMAYER, E
RIEDERER, P
CLINICAL NEUROLOGY AND NEUROSURGERY, 1974, 77 (01) : 15 - 19
[48] ROUTINE OUTPATIENT L-DOPA MONITORING IN ELDERLY PATIENTS WITH PARKINSONS-DISEASE
COPELAND, LG
DUTTON, J
ROBERTS, NB
PLAYFER, JR
AGE AND AGEING, 1994, 23 (02) : 138 - 141
[49] CARDIOVASCULAR EFFECTS OF L-DOPA AND DECARBOXYLASE INHIBITOR IN PATIENTS WITH PARKINSONS-DISEASE
DESJACQUES, P
MORET, P
GAUTHIER, G
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1973, 103 (50) : 1783 - 1785
[50] EARLY DOPAMINE AGONIST THERAPY IN PARKINSONS-DISEASE
RINNE, UK
MOVEMENT DISORDERS, 1989, 4 : S86 - S94

← 1 2 3 4 5 →